Free tool
Stocks listed on Stockholm
We cover 160 companies listed on Stockholm. The median market value in the group is $20.57M. Across the group, the median move over the past trading day is +0.54%. 44% of the 159 with a 200-day average trade above it. Price change over the past year runs from −77.7% to +38.3% across the middle 80 percent of the group, with a median of −24.0%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
160 of 928 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AZN.ST | AstraZeneca PLC | $255.60B | Mega cap | +3.69% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $17.18B | Large cap | +63.16% |
| GETI-B.ST | Getinge AB (publ) | $7.03B | Mid cap | +21.94% |
| SECT-B.ST | Sectra AB (publ) | $5.99B | Mid cap | −10.34% |
| MCOV-B.ST | Medicover AB (publ) | $3.92B | Mid cap | −6.91% |
| CAMX.ST | Camurus AB (publ) | $3.80B | Mid cap | −15.56% |
| BIOA-B.ST | BioArctic AB (publ) | $3.10B | Mid cap | +10.37% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $3.04B | Mid cap | −20.70% |
| EKTA-B.ST | Elekta AB (publ) | $2.16B | Mid cap | +22.79% |
| ALIF-B.ST | AddLife AB (publ) | $2.15B | Mid cap | −4.16% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.96B | Small cap | +14.54% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.96% |
| ALVO-SDB.ST | Alvotech | $1.76B | Small cap | −39.34% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.59B | Small cap | −25.84% |
| NOLA-B.ST | Nolato AB (publ) | $1.51B | Small cap | −4.79% |
| AMBEA.ST | Ambea AB (publ) | $1.46B | Small cap | +38.31% |
| VITR.ST | Vitrolife AB (publ) | $1.39B | Small cap | −28.19% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +14.57% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $936.96M | Small cap | +68.75% |
| MCAP.ST | MedCap AB (publ) | $879.89M | Small cap | −9.69% |
| SYNSAM.ST | Synsam AB (publ) | $864.35M | Small cap | +1.95% |
| DYVOX.ST | Dynavox Group AB (publ) | $855.06M | Small cap | −38.08% |
| APOTEA.ST | Apotea AB (publ) | $845.55M | Small cap | −24.60% |
| ARJO-B.ST | Arjo AB (publ) | $805.01M | Small cap | −15.46% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $587.36M | Small cap | −26.61% |
| HNSA.ST | Hansa Biopharma AB (publ) | $486.19M | Small cap | +40.48% |
| CEVI.ST | CellaVision AB (publ) | $414.65M | Small cap | −2.59% |
| EGTX.ST | Egetis Therapeutics AB (publ) | $394.86M | Small cap | +57.87% |
| HUM.ST | Humana AB (publ) | $355.63M | Small cap | +80.96% |
| VICO.ST | Vicore Pharma Holding AB (publ) | $317.21M | Small cap | −7.55% |
| SUS.ST | Surgical Science Sweden AB (publ) | $280.49M | Small cap | −45.96% |
| STIL.ST | Stille AB | $208.25M | Small cap | −5.17% |
| CARA.ST | Carasent AB (publ) | $189.72M | Small cap | −8.41% |
| SANION.ST | Saniona AB (publ) | $176.56M | Small cap | −7.42% |
| FLERIE.ST | Flerie AB (publ) | $169.95M | Small cap | −48.83% |
| BINV.ST | BioInvent International AB (publ) | $162.19M | Small cap | −26.25% |
| BICO.ST | BICO Group AB (publ) | $152.07M | Small cap | −12.56% |
| GENO.ST | Genovis AB (publ.) | $151.02M | Small cap | −10.69% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $148.07M | Small cap | −54.67% |
| SEDANA.ST | Sedana Medical AB (publ) | $145.13M | Small cap | −7.43% |
| PAX.ST | Paxman AB (publ) | $142.37M | Small cap | −23.33% |
| MVIR.ST | Medivir AB (publ) | $129.64M | Small cap | +1.03% |
| HAMLET-B.ST | Hamlet BioPharma AB (publ) | $123.92M | Small cap | +0.95% |
| CRAD-B.ST | C-Rad AB (publ) | $122.72M | Small cap | +7.36% |
| SYNACT.ST | SynAct Pharma AB | $113.01M | Small cap | +9.21% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $105.97M | Small cap | +116.29% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $104.29M | Small cap | −60.21% |
| NANOFS.ST | Nanoform Finland Oyj | $100.05M | Small cap | +20.65% |
| NANEXA.ST | Nanexa AB (publ) | $94.88M | Micro cap | +119.34% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | $94.87M | Micro cap | +4.46% |
| ONCO.ST | Oncopeptides AB (publ) | $83.29M | Micro cap | −58.44% |
| EQL.ST | EQL Pharma AB (publ) | $77.13M | Micro cap | −69.35% |
| DICOT.ST | Dicot Pharma AB | $75.76M | Micro cap | −77.37% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | $68.48M | Micro cap | −10.26% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $64.65M | Micro cap | −30.04% |
| SEZI.ST | Senzime AB (publ) | $58.17M | Micro cap | −45.48% |
| FLUO.ST | FluoGuide A/S | $56.88M | Micro cap | −18.23% |
| EPIS-B.ST | Episurf Medical AB (publ) | $56.61M | Micro cap | +64.00% |
| MOB.ST | Moberg Pharma AB (publ) | $52.57M | Micro cap | +29.64% |
| XSPRAY.ST | Xspray Pharma AB (publ) | $51.63M | Micro cap | −77.49% |
| CANTA.ST | Cantargia AB (publ) | $50.41M | Micro cap | −26.48% |
| ORX.ST | Orexo AB (publ) | $49.92M | Micro cap | −34.07% |
| IMMU.ST | Mendus AB (publ) | $46.71M | Micro cap | −3.18% |
| CLBIO.ST | Corline Biomedical AB | $46.01M | Micro cap | +30.12% |
| ENZY.ST | Enzymatica AB (publ) | $45.92M | Micro cap | −26.67% |
| OSSD.ST | OssDsign AB (publ) | $43.31M | Micro cap | −75.17% |
| MNTC.ST | Mentice AB (publ) | $40.06M | Micro cap | −1.45% |
| ORT-B.ST | Ortoma AB (publ) | $38.36M | Micro cap | −67.23% |
| IVACC.ST | Intervacc AB (publ) | $37.61M | Micro cap | −10.00% |
| QLINEA.ST | Q-linea AB (publ) | $36.75M | Micro cap | −62.67% |
| SPRINT.ST | Sprint Bioscience AB (publ) | $35.27M | Micro cap | +457.89% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | $35.15M | Micro cap | +3.41% |
| BRAIN.ST | BrainCool AB (publ) | $33.91M | Micro cap | −15.00% |
| ACARIX.ST | Acarix AB (publ) | $31.10M | Micro cap | −15.38% |
| ISOFOL.ST | Isofol Medical AB (publ) | $26.78M | Micro cap | −5.81% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $25.92M | Micro cap | −45.42% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | $25.85M | Micro cap | +87.83% |
| INTEG-B.ST | Integrum AB (publ) | $24.95M | Micro cap | −79.13% |
| SCIB.ST | SciBase Holding AB (publ) | $21.49M | Micro cap | −32.96% |
| XBRANE.ST | Xbrane Biopharma AB (publ) | $20.57M | Micro cap | −74.53% |
| DEX.ST | Dextech Medical AB | $20.11M | Micro cap | +19.65% |
| ELIC.ST | Elicera Therapeutics AB (publ) | $19.08M | Micro cap | −62.23% |
| XINT.ST | Xintela AB (publ) | $18.92M | Micro cap | −50.13% |
| ALZ.ST | Alzinova AB (publ) | $18.38M | Micro cap | −30.08% |
| PRO.ST | Promimic AB (publ) | $17.87M | Micro cap | −39.39% |
| ORTI-A.ST | Ortivus AB (publ) | $17.51M | Micro cap | −35.48% |
| SENZA.ST | SenzaGen AB | $17.29M | Micro cap | −15.96% |
| ABERA.ST | Abera Bioscience AB | $17.06M | Micro cap | −0.38% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | $17.06M | Micro cap | +4.08% |
| INIT.ST | Initiator Pharma A/S | $16.62M | Micro cap | −35.62% |
| DMYD-B.ST | Diamyd Medical AB (publ) | $16.58M | Micro cap | −90.94% |
| ACUC.ST | AcuCort AB (publ) | $15.77M | Micro cap | +4.70% |
| NICA.ST | Nanologica AB (publ) | $15.76M | Micro cap | −67.40% |
| ORTI-B.ST | Ortivus AB (publ) | $15.23M | Micro cap | +38.56% |
| IZAFE-B.ST | iZafe Group AB (publ) | $14.49M | Micro cap | −1.47% |
| ACTI.ST | Active Biotech AB (publ) | $14.46M | Micro cap | −63.57% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | $14.33M | Micro cap | −32.87% |
| NOSA.ST | Nosa Plugs AB | $13.81M | Micro cap | −31.29% |
| PTRK.ST | Physitrack PLC | $13.60M | Micro cap | −62.10% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.16M | Micro cap | −35.52% |
| BOUL.ST | Boule Diagnostics AB (publ) | $13.06M | Micro cap | −48.72% |
| NXTCL.ST | NextCell Pharma AB | $12.46M | Micro cap | −9.06% |
| ARCOMA.ST | Arcoma AB | $12.39M | Micro cap | −4.26% |
| ICO.ST | Iconovo AB (publ) | $12.23M | Micro cap | −51.21% |
| VIVE.ST | Vivesto AB | $10.45M | Micro cap | −56.92% |
| ONCOZ.ST | OncoZenge AB (publ) | $10.32M | Micro cap | −23.08% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | $10.11M | Micro cap | −14.72% |
| BIBB.ST | BiBBInstruments AB | $10.08M | Micro cap | −84.80% |
| IMMNOV.ST | Immunovia AB (publ) | $10.03M | Micro cap | −69.92% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | $9.98M | Micro cap | −45.40% |
| IDLDX.ST | IDL Diagnostics AB (publ) | $9.78M | Micro cap | −4.49% |
| SPAGO.ST | Spago Nanomedical AB (publ) | $9.69M | Micro cap | −56.74% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | $9.31M | Micro cap | −77.84% |
| ACE.ST | Ascelia Pharma AB (publ) | $8.77M | Micro cap | −87.31% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | $8.05M | Micro cap | −2.70% |
| PILA.ST | Pila Pharma AB (publ) | $7.20M | Micro cap | −26.60% |
| PEXA-B.ST | PExA AB (publ) | $7.17M | Micro cap | +69.34% |
| ACOU.ST | AcouSort AB (publ) | $7.12M | Micro cap | +8.39% |
| SYNT.ST | SyntheticMR AB (publ) | $7.02M | Micro cap | −73.79% |
| CHOSA.ST | Chosa Oncology AB | $6.96M | Micro cap | −15.32% |
| ERMA.ST | Enorama Pharma AB (publ) | $6.68M | Micro cap | −66.59% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | $6.53M | Micro cap | −79.77% |
| NEOLA.ST | Neola Medical AB (publ) | $5.98M | Micro cap | −79.22% |
| QLIFE.ST | Qlife Holding AB (publ) | $5.87M | Micro cap | −54.72% |
| REDS.ST | Redsense Medical AB (publ) | $5.79M | Micro cap | −36.80% |
| FLUI.ST | Fluicell AB (publ) | $5.70M | Micro cap | +287.00% |
| SDOS.ST | ScandiDos AB (publ) | $5.27M | Micro cap | −34.08% |
| ODI.ST | ODI Pharma AB (publ) | $5.17M | Micro cap | +74.03% |
| SERV.ST | Servana AB | $5.01M | Micro cap | +100.00% |
| KONT.ST | Kontigo Care AB (publ) | $4.82M | Micro cap | −43.48% |
| BIOSGN.ST | Biosergen AB (publ) | $4.39M | Micro cap | −95.53% |
| AINO.ST | Aino Health AB (publ) | $4.24M | Micro cap | −18.85% |
| PMED.ST | PEPTONIC medical AB (publ) | $3.48M | Micro cap | −14.29% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | $3.19M | Micro cap | −94.61% |
| SPERM.ST | Spermosens AB (publ) | $3.13M | Micro cap | +24.32% |
| GUARD.ST | Disruptive Pharma AB (publ) | $3.11M | Micro cap | −93.42% |
| PERP-B.ST | Perpetua Medical AB (publ) | $2.84M | Micro cap | −38.34% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $2.79M | Micro cap | +3.33% |
| PROGEN.ST | Prostatype Genomics AB (publ) | $2.59M | Micro cap | −77.67% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | $2.51M | Micro cap | −60.42% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | $2.21M | Micro cap | −60.00% |
| GABA.ST | Gabather AB (publ) | $2.21M | Micro cap | −2.27% |
| PHAL.ST | PharmaLundensis AB | $2.14M | Micro cap | +37.83% |
| POLAR.ST | PolarCool AB (publ) | $2.11M | Micro cap | −67.32% |
| RESP.ST | Respiratorius AB (publ) | $2.05M | Micro cap | −33.60% |
| ATORX.ST | Alligator Bioscience AB (publ) | $2.02M | Micro cap | −99.27% |
| SPEC.ST | SpectraCure AB (publ) | $1.99M | Micro cap | −84.73% |
| IMS.ST | Invent Medic Sweden AB (publ) | $1.89M | Micro cap | −26.67% |
| MONI.ST | Monivent AB | $1.43M | Micro cap | −8.27% |
| APTA.ST | Aptahem AB (publ) | $1.42M | Micro cap | −70.17% |
| NANECH.ST | NanoEcho AB (publ) | $1.37M | Micro cap | −76.92% |
| 2CUREX.ST | 2cureX AB (publ) | $1.25M | Micro cap | −79.92% |
| ODIN.ST | Odinwell AB (publ) | $1.21M | Micro cap | −57.21% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | $907.22K | Micro cap | −98.18% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | $858.30K | Micro cap | −70.73% |
| LXB.ST | Luxbright AB (publ) | $793.05K | Micro cap | −91.91% |
| S2M.ST | S2Medical AB (publ) | $604.05K | Micro cap | −66.15% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | $497.69K | Micro cap | −73.53% |
| SDET.ST | SensoDetect Aktiebolag (publ) | $148.73K | Micro cap | −99.53% |
| IMP-A-SDB.ST | Implantica AG | — | — | −14.45% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.